EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors

S Egyhazi Brage, F Costa Svedman, M Bergqvist, H Helgadottir

Immuno-Oncology and Technology · 2026-06 · 30 · 101595

DOI: 10.1016/j.iotech.2026.101595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immuno-Oncology and Technology, 2026-06. Verfasst von S Egyhazi Brage und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet, Cancer Research Foundations of Radiumhemmet, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkersimmunotherapyinflammation proteinsmelanomathymidine kinase activity

Autor:innen und Institutionen

  • Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
  • Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Biovica, Uppsala, Sweden.

Förderung

  • Karolinska Institutet
  • Cancer Research Foundations of Radiumhemmet
  • Cancerfonden

Zitieren

APA

Egyhazi Brage, S., Costa Svedman, F., Bergqvist, M., & Helgadottir, H. (2026). Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors. Immuno-Oncology and Technology, 30, 101595. https://doi.org/10.1016/j.iotech.2026.101595

Vancouver

Egyhazi Brage S, Costa Svedman F, Bergqvist M, Helgadottir H. Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors. Immuno-Oncology and Technology. 2026;30:101595. doi:10.1016/j.iotech.2026.101595

BibTeX
@article{EgyhaziBrage2026,
  author = {Egyhazi Brage, S and Costa Svedman, F and Bergqvist, M and Helgadottir, H},
  title = {Combining circulating inflammatory proteins and thymidine kinase activity to predict survival in melanoma patients receiving immune checkpoint inhibitors},
  journal = {Immuno-Oncology and Technology},
  year = {2026},
  volume = {30},
  pages = {101595},
  doi = {10.1016/j.iotech.2026.101595}
}
Kostenlos starten →